CRISPR Therapeutics (CRSP) PT Raised to $82 at Needham
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $53.55 --0%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 10
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 10
Join SI Premium – FREE
Needham analyst Gil Blum raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $82.00 (from $80.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Allianz SE (ALV:GR) (AZSEY) PT Raised to EUR460 at JPMorgan
- NKT A/S (NKT:DC) PT Raised to DKK917 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
